Barbigerone inhibits tumor angiogenesis, growth and metastasis in melanoma

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 1, 2014, Pages 167-174

  Yang, Jian Hong ^a   Hu, Jia ^a   Wan, Li ^b   Chen, Li Juan ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Angiogenesis; Barbigerone; Melanoma cancer; Metastasis; P38 MAP kinase

Indexed keywords

ANGIOGENESIS INHIBITOR; BARBIGERONE; CD31 ANTIGEN; FOCAL ADHESION KINASE 1; ISOFLAVONE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

ANIMAL; ARTICLE; C57BL MOUSE; CELL MOTION; CELL PROLIFERATION; DRUG EFFECT; EXPERIMENTAL MELANOMA; HUMAN; LUNG TUMOR; METABOLISM; METASTASIS; MICROVASCULATURE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION; ZEBRA FISH;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD31; CELL MOVEMENT; CELL PROLIFERATION; FOCAL ADHESION KINASE 1; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; ISOFLAVONES; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICROVESSELS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; ZEBRAFISH;

EID: 84894059840     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.1.167     Document Type: Article

References (34)

1. Amundadottir LT, Leder P (1998). Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene, 16, 737-46.
2. Carmeliet P (2003). Angiogenesis in health and disease. Nat Med, 9, 653-60.
3. Carmeliet P, Base M (2008). Metabolism and therapeutic angiogenesis. N Engl J Med, 358, 2511-2.
4. Carmeliet P, Jain RK (2000). Angiogenesis in cancer and other diseases. Nature, 407, 249-57.
5. Davidson B, Konstantinovsky S, Kleinberg L, et al (2006). The mitogen-activated protein kinases (MAPK). p38 and JNK are markers of tumor progression in breast carcinoma. Gynecol Oncol, 102, 453-61.
6. Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN (2006). Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci, 27, 297-309.
7. Ferrara N, Kerbel RS (2005). Angiogenesis as a therapeutic target. Nature, 438, 967-74.
8. Folkman J (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med, 285, 1182-6.
9. Folkman J, Shing Y (1992). Angiogenesis. J Biol Chem, 267, 10931-4.
10. Gupta GP, Massague J (2006). Cancer metastasis: building a framework. Cell, 127, 679-95.
11. Johnson GL, Lapadat R (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 298, 1911-2.
12. Hsia DA, Mitra SK, Hauck CR, et al (2003). Differential regulation of cell motility and invasion by FAK. J Cell Biol, 160, 753-67.
13. Huang D, Ding Y, Luo WM, et al (2008). Inhibition of MAPK Kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res, 68, 81-8.
14. Kruger EA, Duray PH, Price DK, Pluda JM, Figg WD (2001). Approaches to preclinical screening of antiangiogenic agents. Semin Oncol, 28, 570-6.
15. Lee JC, Laydon JT, Mcdonnell PC, et al (1994). A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature, 372, 739-46.
16. Li X, Wang X, Ye H, Peng A, Chen L (2012). Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.Cancer Chemother Pharmacol, 70, 425-37.
17. Olson MF, Sahai E (2009). The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis, 26, 273-87.
18. Patan S (2004). Vasculogenesis and angiogenesis. Cancer Treat Res, 117, 3-32.
19. Raingeaud J, Gupta S, Rogers JS, et al (1995). Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem, 31, 270, 7420-6.
20. Reddy KB, Nabha SM, Atanaskova N (2003). Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev, 22, 395-403.
21. Small JV, Rottner K, Kaverina I, Anderson KI (1998). Assembling an actin cytoskeleton for cell attachment and movement. Biochim Biophys Acta, 1404, 271-81.
22. Tournaire R, Simon MP, le Noble F, et al (2004). A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor. EMBO Rep, 5, 262-7.
23. Tozer GM, Kanthou C, Baguley BC (2005). Disrupting tumor blood vessels. Nat Rev Cancer, 5, 423-35.
24. Uzgare AR, Kaplan PJ, Greenberg NM (2003). Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer. Prostate, 55, 128-39.
25. Vicent S, Garayoa M, Lopez-Picazo JM, et al (2004). Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Clin Cancer Res, 10, 3639-49.
26. Vilain C (1980). Barbigerone, a new pyranoisoflavone from seeds of Tephrosia barbigera. Phytochem, 19, 988-9.
27. Wangensteen H, Alamgir M, Rajia S, Samuelsen AB, Malterud KE (2005). Rotenoids and isoflavones from Sarcolobus globosus. Planta Med, 71, 754-8.
28. Wangensteen H, Miron A, Alamgir M, et al (2006). Antioxidant and 15-lipoxygenase inhibitory activity of rotenoids, isoflavones and phenolic glycosides from Sarcolobus globosus. Fitoterapia, 77, 290-5.
29. Webb CP, Van Aelst L, Wigler MH, Woude GF (1998). Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci USA, 95, 8773-8.
30. Ye HY, Zhong SJ, Li YF, et al (2010). Enrichment and isolation of barbigerone from Millettia pachycarpa Benth. using highspeed counter-current chromatography and preparative HPLC. J Sep Sci, 33, 1010-7.
31. Yenesew A, Derese S, Midiwo JO, Oketch-Rabah HA, Lisgarten J, Palmer R, et al (2003). Anti-plasmodial activities and X-ray crystal structures of rotenoids from Millettia usaramensis subspecies usaramensis". Phytochem, 64, 773-9.
32. Yenesew A, Midiwo JO, Waterman PG (1998). Rotenoids, isoflavones and chalcones from the stem bark of Millettia usaramensis subspecies usaramensis. Phytochem, 47, 295-300.
33. Zhao CJ, Yang HS, Shi HS, et al (2011). Distinct Contributions of Angiogenesis and Vascular Co-option during the Initiation of Microtumors and Micrometastases. Carcinogenesis, 32, 1143-50.
34. Zhang D, Li B, Shi J, et al (2010). Suppression of Tumor Growth and Metastasis by Simultaneously Blocking Vascular Endothelial Growth Factor (VEGF).-A and VEGF-C with a Receptor-Immunoglobulin Fusion Protein. Cancer Res, 70, 2495-503.